PMID- 27783183 OWN - NLM STAT- MEDLINE DCOM- 20170214 LR - 20181113 IS - 1590-3478 (Electronic) IS - 1590-1874 (Linking) VI - 38 IP - 1 DP - 2017 Jan TI - Association of sudomotor function with peripheral artery disease in type 2 diabetes. PG - 151-156 LID - 10.1007/s10072-016-2742-3 [doi] AB - Peripheral artery disease (PAD) is the major risk factor for cardiovascular disease and lower extremity amputation in patients with diabetes. Autonomic neuropathy is a risk factor for cardiovascular-related morbidity and mortality. Sudomotor dysfunction is well established in type 2 diabetes mellitus (T2DM) and reflects small fibre neuropathy, cardiovascular autonomic neuropathy and peripheral sympathetic autonomic neuropathy. However, the relationship between sudomotor dysfunction and PAD remains unexplored. Therefore, the aim of present study was to explore the association of sudomotor function with ankle-brachial index (ABI) and C-reactive protein (CRP) in T2DM. In this cross-sectional study, we recruited 36 consecutive type 2 diabetes patients and 20 age- and sex-matched healthy controls. Sudomotor function was assessed using Sudoscan (Sudoscan-Impeto Medical Device, EZS 01750010193, Paris, France), which detects sweat gland function through measurement of electrochemical skin conductance of both hands and feet. Measurement of ankle-brachial ABI was carried out with sphygmomanometer and Doppler device (Hadeco Bidop ES-100V3). Glycated haemoglobin (HbA1c), fasting plasma glucose, and inflammatory marker CRP were also measured. Type 2 diabetic patients had significantly impaired sudomotor function (48.14 +/- 8.28 vs. 76.48 +/- 6.72 micros), lower ABI (0.89 +/- 0.25 vs. 1.15 +/- 0.11) and elevated CRP (5.32 +/- 2.41 vs. 2.45 +/- 1.11 mg/l) as compared to healthy controls, respectively (p < 0.01). Sudoscan scores were found to be inversely correlated with CRP and HbA1c, and directly correlated with ABI (p < 0.05) in the patients. Sudomotor dysfunction is associated with significant peripheral artery disease, vascular inflammation and impaired glycaemic status. FAU - Chahal, Simran AU - Chahal S AD - Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, Punjab, India. FAU - Vohra, Kanchan AU - Vohra K AD - Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, Punjab, India. kanchanvohra34@gmail.com. FAU - Syngle, Ashit AU - Syngle A AD - Healing Touch City Clinic, # 547, Sector 16-D, Chandigarh, 160015, India. AD - Fortis Multi Speciality Hospital, Mohali, Punjab, India. LA - eng PT - Journal Article DEP - 20161025 PL - Italy TA - Neurol Sci JT - Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology JID - 100959175 RN - 0 (Biomarkers) RN - 0 (Blood Glucose) SB - IM MH - Adult MH - Autonomic Nervous System/*physiopathology MH - Autonomic Nervous System Diseases/*diagnosis/physiopathology MH - Biomarkers/blood MH - Blood Glucose MH - Diabetes Mellitus, Type 2/*complications/physiopathology MH - Diabetic Neuropathies/*diagnosis/physiopathology MH - Female MH - Humans MH - Male MH - Middle Aged MH - Peripheral Arterial Disease/*complications/physiopathology MH - Risk Factors OTO - NOTNLM OT - Peripheral artery disease OT - Sudomotor dysfunction OT - Type 2 diabetes OT - Vascular inflammation EDAT- 2016/10/27 06:00 MHDA- 2017/02/15 06:00 CRDT- 2016/10/27 06:00 PHST- 2016/07/07 00:00 [received] PHST- 2016/10/17 00:00 [accepted] PHST- 2016/10/27 06:00 [pubmed] PHST- 2017/02/15 06:00 [medline] PHST- 2016/10/27 06:00 [entrez] AID - 10.1007/s10072-016-2742-3 [pii] AID - 10.1007/s10072-016-2742-3 [doi] PST - ppublish SO - Neurol Sci. 2017 Jan;38(1):151-156. doi: 10.1007/s10072-016-2742-3. Epub 2016 Oct 25.